Pharming Group N.V. (PHAR) Stock Fundamentals & Financials

Pharming Group N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Fabrice Chouraqui, with a market cap of $726.2M.

Market cap

$726.18M-13.8%

We’re still putting together Pharming Group N.V.’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Pharming Group N.V. up the queue, and we’ll analyze its filings next.

Earnings

Q2 2026 report

July 30, 2026

Revenue$90.2MMiss by $9.3M EPS$0.02Miss by $0.04

Read the full report

Next report

Date not yet announced

Profile

CountryNetherlands

Listed2020

Employees382.0

CEOFabrice Chouraqui

SectorHealthcare

IndustryBiotechnology

Websitepharming.com

FilingsSEC EDGAR